ALNYLAM PHARMACEUTICALS Stock Price
$28.01 
Change:
0.85 1.56% Volume:
15,907
Live Stock Prices
You need Flash Player to see the chart, please download from the link below
Todays Chart
You need Flash Player to see the chart, please download from the link below
Month Chart
Todays High: 28.1 | Todays Low: 26.63 | Open: 27.16 | Last Close: 27.82
52 Wk High: 29 | 52 Wk Low: 9.98 | Todays Pivot: 27.58 | Pre market open: 20.37
Sector: 
Online News For Alnylam Pharmaceuticals
|
Alnylam Pharmaceuticals' CEO Presents at 2013 Bank of America Merrill Lynch ... - Seeking Alpha
Thu, 16 May 2013 18:25Alnylam Pharmaceuticals, Inc. (ALNY) 2013 Bank of America Merrill Lynch Health Care Conference Call May 16, 2013 11:40 AM ET. Steve Byrne - Bank of America Merrill Lynch. Welcome to the last day of the BofA Healthcare Conference. My name is Steve ...
|
|
ALNYLAM PHARMACEUTICALS, INC. : Alnylam to Webcast Presentation at ... - 4-traders (press release)
Tue, 21 May 2013 20:03Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that management will present a company overview at the Deutsche Bank 38th Annual dbAccess Health Care Conference on Wednesday, May 29, 2013 ...
|
|
NASDAQ Gainers Watch List: Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN ... - SBWire (press release)
Sun, 19 May 2013 01:00Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) a biopharmaceutical company that engages in discovering, developing, and commercializing novel therapeutics based on RNA interference closed up in its previous session (+0.85%) on 520,072 shares traded ...
|
|
ALNYLAM PHARMACEUTICALS, INC. : Alnylam Presents Key Pre-Clinical Proof ... - 4-traders (press release)
Fri, 17 May 2013 12:08Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, announced today that it has presented key pre-clinical proof-of-concept data from its RNAi therapeutic program targeting aminolevulinate synthase-1 (ALAS-1) for the ...
|
|
Alnylam Pharmaceuticals Reports First Quarter 2013 Financial Results - DailyFinance
Tue, 07 May 2013 13:29CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Alnylam Pharmaceuticals, Inc. (NAS: ALNY) , a leading RNAi therapeutics company, today reported its consolidated financial results for the first quarter 2013, and company highlights. "This quarter we continued to ...
|
|
ALNYLAM PHARMACEUTICALS, INC. : Alnylam to Webcast Conference Call ... - 4-traders (press release)
Mon, 29 Apr 2013 20:06Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that it will report financial results for the first quarter ending March 31, 2013 on Monday, May 6, 2013, after the U.S. financial markets close ...
|
ALNY Chart
You need Flash Player to see the chart, please download from the link below
Want To Add This Quote To Your Site?
With our stock widgets you can add a real time Alnylam Pharmaceuticals quote to your website to keep your users up to date with the market. We have a variety of different styled widgets for ALNY to choose from. Visit here to build your stock quote widget »
